Technical Analysis for ALZN - Alzamend Neuro, Inc.

Grade Last Price % Change Price Change
F 1.31 -6.43% -0.09
ALZN closed down 6.43 percent on Wednesday, November 20, 2024, on 47 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bullish Engulfing Bullish -6.43%
Stochastic Buy Signal Bullish -6.43%
Lower Bollinger Band Walk Weakness -6.43%
New 52 Week Low Weakness -6.43%
Lower Bollinger Band Touch Weakness -6.43%

   Recent Intraday Alerts

Alert Time
Down 5% about 20 hours ago
Fell Below Lower Bollinger Band about 20 hours ago
60 Minute Opening Range Breakdown about 20 hours ago
Lower Bollinger Band Support about 21 hours ago
Down 3% about 22 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Alzamend Neuro, Inc., a preclinical stage biopharmaceutical company, focuses on developing products for the treatment of neurodegenerative diseases and psychiatric disorders. The company's lead product candidate is AL001 for the treatment of Alzheimer's and other neurodegenerative diseases and psychiatric disorders. It is also developing AL002, a cell-based therapeutic vaccine, which seeks to restore the ability of the patient's immunological system to Alzheimer's. The company was incorporated in 2016 and is headquartered in Tampa, Florida.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Biology Medication Neuroscience Alzheimer's Disease Neurodegenerative Diseases Dementia Psychiatric Diagnosis Amyloidosis Neurodegeneration Preclinical Stage Biopharmaceutical Psychiatric Disorders Treatment Of Neurodegenerative Diseases Treatment Of Alzheimer's

Is ALZN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.06
52 Week Low 1.25
Average Volume 249,974
200-Day Moving Average 4.99
50-Day Moving Average 1.62
20-Day Moving Average 1.52
10-Day Moving Average 1.44
Average True Range 0.13
RSI (14) 31.97
ADX 14.9
+DI 14.39
-DI 23.52
Chandelier Exit (Long, 3 ATRs) 1.35
Chandelier Exit (Short, 3 ATRs) 1.64
Upper Bollinger Bands 1.72
Lower Bollinger Band 1.31
Percent B (%b) 0.0
BandWidth 27.38
MACD Line -0.10
MACD Signal Line -0.09
MACD Histogram -0.0102
Fundamentals Value
Market Cap 8.67 Million
Num Shares 6.62 Million
EPS -2.28
Price-to-Earnings (P/E) Ratio -0.57
Price-to-Sales 0.00
Price-to-Book 7.23
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.51
Resistance 3 (R3) 1.51 1.46 1.47
Resistance 2 (R2) 1.46 1.41 1.45 1.46
Resistance 1 (R1) 1.38 1.38 1.36 1.38 1.45
Pivot Point 1.33 1.33 1.31 1.32 1.33
Support 1 (S1) 1.25 1.28 1.23 1.25 1.17
Support 2 (S2) 1.20 1.25 1.19 1.16
Support 3 (S3) 1.12 1.20 1.15
Support 4 (S4) 1.12